Current Applications and Challenges of Exosome in COVID-19: A Review
DOI:
https://doi.org/10.54097/hset.v54i.9727Keywords:
COVID-19, Exosomes, Diagnosis, Prevention, Treatment.Abstract
The exosome is a nano-extracellular vesicle secreted by the cell, encasing proteins, nucleic acids, and lipids, among others. Its specific structural composition gives it a role in the medical field. It may act as biomarkers, vaccines and drug carriers. Since the outbreak of COVID-19, the rate of infection has increased dramatically worldwide, as it targets ACE2 in a wide range of human cells, posing a huge threat of loss to human and global health as well as the economy. Exosomes are highly investigated as a highly promising candidate when exploring prevention and treatment against COVID-19. Many experiments have been performed to demonstrate the potential of exosomes in a sufficiently well-documented manner. In this review, we summarize the potential of exosomes in the diagnosis, prevention and treatment of COVID-19, and analyze the problems, with the aim of providing valuable directions for further research on exosomes in the future.
Downloads
References
He, C., et al., Exosome Theragnostic: Biology and Translational Medicine. Theragnostic, 2018. 8 (1): p. 237 - 255.
Zhang, Y., et al., Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications. Int J Nanomedicine, 2020. 15: p. 6917 - 6934.
Gurung, S., et al., The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal, 2021. 19 (1): p. 47.
Whitford, W. and P. Guterstam, Exosome manufacturing status. Future Medicinal Chemistry, 2019. 11 (10): p. 1225 - 1236.
Li, X., et al., Challenges and opportunities in exosome research—Perspectives from biology, engineering, and cancer therapy. APL Bioengineering, 2019. 3 (1): p. 011503.
Xu, Z., et al., Exosome-based immunotherapy: a promising approach for cancer treatment. Molecular Cancer, 2020. 19 (1): p. 160.
Rezaie, J., M. Feghhi, and T. Etemadi, A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Communication and Signaling, 2022. 20 (1): p. 145.
Zhang, J.-j., et al., Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clinical Reviews in Allergy & Immunology, 2023. 64 (1): p. 90 - 107.
Chow, E.J., T.M. Uyeki, and H.Y. Chu, The effects of the COVID-19 pandemic on community respiratory virus activity. Nature Reviews Microbiology, 2023. 21 (3): p. 195 - 210.
Yuki, K., M. Fujiogi, and S. Koutsogiannaki, COVID-19 pathophysiology: A review. Clinical Immunology, 2020. 215: p. 108427.
Babaei, G., et al., Exosomes and COVID-19: challenges and opportunities. Comparative Clinical Pathology, 2022. 31 (2): p. 347 - 354.
Falzone, L., et al., Current and innovative methods for the diagnosis of COVID‑19 infection (Review). Int J Mol Med, 2021. 47 (6): p. 100.
Barouch, D.H., Covid-19 Vaccines — Immunity, Variants, Boosters. New England Journal of Medicine, 2022. 387 (11): p. 1011 - 1020.
Gregoriadis, G., Liposomes and mRNA: Two technologies together create a COVID-19 vaccine. Medicine in Drug Discovery, 2021. 12: p. 100104.
Ndwandwe, D. and C.S. Wiysonge, COVID-19 vaccines. Current Opinion in Immunology, 2021. 71: p. 111 - 116.
Robinson, P.C., et al., COVID-19 therapeutics: Challenges and directions for the future. Proceedings of the National Academy of Sciences, 2022. 119 (15): p. e2119893119.
Hassanpour, M., et al., The role of extracellular vesicles in COVID-19 virus infection. Infection, Genetics and Evolution, 2020. 85: p. 104422.
Gurunathan, S., M.H. Kang, and J.H. Kim, Diverse Effects of Exosomes on COVID-19: A Perspective of Progress from Transmission to Therapeutic Developments. Front Immunol, 2021. 12: p. 716407.
Rezabakhsh, A., et al., Application of exosomes for the alleviation of COVID-19-related pathologies. Cell Biochem Funct, 2022. 40 (5): p. 430 - 438.
Chavda, V.P., et al., Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants. Vaccines, 2023. 11 (2): p. 374.
Hernández-Díazcouder, A., C. Díaz-Godínez, and J.C. Carrero, Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update. Applied Microbiology and Biotechnology, 2023. 107 (7): p. 2131 - 2141.
Wang, Z., et al., Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. Nature Biomedical Engineering, 2022. 6 (7): p. 791 - 805.
Wu, C., et al., Neutralization of SARS-CoV-2 pseudo virus using ACE2-engineered extracellular vesicles. Acta Pharmaceutica Sinica B, 2022. 12 (3): p. 1523 - 1533.
Popowski, K.D., et al., Exosome therapeutics for COVID-19 and respiratory viruses. View (Beijing), 2021. 2 (3): p. 20200186.
Rao, L., R. Tian, and X. Chen, Cell-Membrane-Mimicking Nanodecoys against Infectious Diseases. ACS Nano, 2020. 14 (3): p. 2569 - 2574.
Yoo, K. H., et al., Possibility of exosome‑based coronavirus disease 2019 vaccine (Review). Mol Med Rep, 2022. 25 (1): p. 26.
Jayaramayya, K., et al., Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment. BMB Rep, 2020. 53 (8): p. 400 - 412.
Kaffash Farkhad, N., A. Mahmoudi, and E. Mahdipour, Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms. Regenerative Therapy, 2022. 20: p. 61 - 71.
Li, Y., et al., Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis. Advanced Materials, 2022. 34 (19): p. 2108476.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
